These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 16054887)

  • 1. The structure and function of oxidized albumin in hemodialysis patients: Its role in elevated oxidative stress via neutrophil burst.
    Mera K; Anraku M; Kitamura K; Nakajou K; Maruyama T; Otagiri M
    Biochem Biophys Res Commun; 2005 Sep; 334(4):1322-8. PubMed ID: 16054887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive oxygen species damaged human serum albumin in patients with type 1 diabetes mellitus: biochemical and immunological studies.
    Rasheed Z; Ali R
    Life Sci; 2006 Nov; 79(24):2320-8. PubMed ID: 16945391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive oxygen species damaged human serum albumin in patients with hepatocellular carcinoma.
    Rasheed Z; Ahmad R; Rasheed N; Ali R
    J Exp Clin Cancer Res; 2007 Sep; 26(3):395-404. PubMed ID: 17987802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidation and carboxy methyl lysine-modification of albumin: possible involvement in the progression of oxidative stress in hemodialysis patients.
    Mera K; Anraku M; Kitamura K; Nakajou K; Maruyama T; Tomita K; Otagiri M
    Hypertens Res; 2005 Dec; 28(12):973-80. PubMed ID: 16671336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairments of the biological properties of serum albumin in patients on haemodialysis.
    Lim PS; Cheng YM; Yang SM
    Nephrology (Carlton); 2007 Feb; 12(1):18-24. PubMed ID: 17295656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced recognition of reactive oxygen species damaged human serum albumin by circulating systemic lupus erythematosus autoantibodies.
    Rasheed Z; Ahmad R; Rasheed N; Ali R
    Autoimmunity; 2007 Nov; 40(7):512-20. PubMed ID: 17966041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialyzable uremic solutes contribute to enhanced oxidation of serum albumin in regular hemodialysis patients.
    Terawaki H; Nakayama K; Matsuyama Y; Nakayama M; Sato T; Hosoya T; Era S; Ito S
    Blood Purif; 2007; 25(3):274-9. PubMed ID: 17460395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure.
    Witko-Sarsat V; Friedlander M; Nguyen Khoa T; Capeillère-Blandin C; Nguyen AT; Canteloup S; Dayer JM; Jungers P; Drüeke T; Descamps-Latscha B
    J Immunol; 1998 Sep; 161(5):2524-32. PubMed ID: 9725252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
    Nishio T; Takamura N; Nishii R; Tokunaga J; Yoshimoto M; Kawai K
    Nephrol Dial Transplant; 2008 Jul; 23(7):2304-10. PubMed ID: 18390890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative modification of albumin in predialysis, hemodialysis, and peritoneal dialysis patients.
    Mitrogianni Z; Barbouti A; Galaris D; Siamopoulos KC
    Nephron Clin Pract; 2009; 113(3):c234-40. PubMed ID: 19690441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein thiol oxidation and lipid peroxidation in patients with uraemia.
    Prakash M; Upadhya S; Prabhu R
    Scand J Clin Lab Invest; 2004; 64(6):599-604. PubMed ID: 15370466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The redox state of albumin and serious cardiovascular incidence in hemodialysis patients.
    Terawaki H; Takada Y; Era S; Funakoshi Y; Nakayama K; Nakayama M; Ogura M; Ito S; Hosoya T
    Ther Apher Dial; 2010 Oct; 14(5):465-71. PubMed ID: 21175544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of albumin properties in patients with chronic renal failure.
    Pieniazek A; Brzeszczynska J; Kruszynska I; Gwozdzinski K
    Free Radic Res; 2009 Oct; 43(10):1008-18. PubMed ID: 19707919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and binding properties of serum albumin in uremic patients at different periods of hemodialysis.
    Sarnatskaya VV; Ivanov AI; Nikolaev VG; Rotellar E; von Appen K; Haspar M; Maslenny VN; Klinkmann H
    Artif Organs; 1998 Feb; 22(2):107-15. PubMed ID: 9491899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study.
    Anraku M; Kitamura K; Shintomo R; Takeuchi K; Ikeda H; Nagano J; Ko T; Mera K; Tomita K; Otagiri M
    Clin Biochem; 2008 Oct; 41(14-15):1168-74. PubMed ID: 18692036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemia modified albumin and carbonyl protein as potential biomarkers of protein oxidation in hemodialysis.
    Albarello K; dos Santos GA; Bochi GV; Sangoi MB; Almeida TC; Paz da Silva JE; Garcia SC; Moresco RN
    Clin Biochem; 2012 Apr; 45(6):450-4. PubMed ID: 22342921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of oxidized human serum albumin. A slight structural change impairs its ligand-binding and antioxidant functions.
    Kawakami A; Kubota K; Yamada N; Tagami U; Takehana K; Sonaka I; Suzuki E; Hirayama K
    FEBS J; 2006 Jul; 273(14):3346-57. PubMed ID: 16857017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global assessment of serum antioxidant status in hemodialysis patients.
    Mircescu G; Capuşă C; Stoian I; Vârgolici B; Barbulescu C; Ursea N
    J Nephrol; 2005; 18(5):599-605. PubMed ID: 16299688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between dialysate oxidized protein and peritoneal membrane transport properties in patients on peritoneal dialysis.
    Latcha S; Hong S; Gibbons N; Kohn N; Mattana J
    Nephrol Dial Transplant; 2008 Oct; 23(10):3295-301. PubMed ID: 18443211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of olmesartan on oxidative stress in hemodialysis patients.
    Kadowaki D; Anraku M; Tasaki Y; Kitamura K; Wakamatsu S; Tomita K; Gebicki JM; Maruyama T; Otagiri M
    Hypertens Res; 2007 May; 30(5):395-402. PubMed ID: 17587751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.